United-Guardian conducts research, product development, manufacturing and marketing of cosmetic ingredients, pharmaceuticals, medical products, and proprietary specialty industrial products. Co.'s research and development department modifies, refines, and expands the uses of existing products for additional uses and markets. Co. has a range of products, many of which are marketed and some of which are still in the research and development stage. Of the products being marketed, the two primary product lines are the Lubrajel® line of cosmetic ingredients and medical lubricants, and Renacidin® Irrigation Solution, a pharmaceutical product. We show 51 historical shares outstanding datapoints in our coverage of UG's shares outstanding history.
Understanding the changing numbers of UG shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like UG versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching UG by allowing them to research UG shares outstanding history
as well as any other stock in our coverage universe. |